Literature DB >> 8202529

Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse.

H Xu1, P Christmas, X R Wu, U M Wewer, E Engvall.   

Abstract

M-laminin is a major member of the laminin family of basement membrane proteins. It is prominently expressed in striated muscle and peripheral nerve. M-laminin is deficient in patients with the autosomal recessive Fukuyama congenital muscular dystrophy but is normal in patients with the sex-linked Duchenne and Becker muscular dystrophies. We have examined M-laminin expression in mice with autosomal recessive muscular dystrophy caused by the mutation dy. The heavy chain of M-laminin was undetectable in skeletal muscle, heart muscle, and peripheral nerve by immunofluorescence and immunoblotting in homozygous dystrophic dy/dy mice but was normal in heterozygous and wild-type nondystrophic mice. Immunofluorescence confirmed the presence of other major basement membrane proteins in the dystrophic mice. Very low levels of M-laminin heavy chain mRNA were detected by Northern blotting of muscle and heart tissue from dy/dy mice, suggesting that M-laminin heavy-chain mRNA may be produced at very low levels or is unstable. Information about the chromosomal localization of the M heavy-chain in human and mouse suggests that a mutation in the M-chain gene causes the muscular dystrophy in dy/dy mice. The dy mouse may provide a model for autosomal muscular dystrophies in humans and facilitate studies of functions of M-laminin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202529      PMCID: PMC44038          DOI: 10.1073/pnas.91.12.5572

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Genetically determined defect of Schwann cell basement membrane in dystrophic mouse.

Authors:  R E Madrid; E Jaros; M J Cullen; W G Bradley
Journal:  Nature       Date:  1975-09-25       Impact factor: 49.962

Review 2.  Structure and function of laminin: anatomy of a multidomain glycoprotein.

Authors:  K Beck; I Hunter; J Engel
Journal:  FASEB J       Date:  1990-02-01       Impact factor: 5.191

3.  Merosin, a tissue-specific basement membrane protein, is a laminin-like protein.

Authors:  K Ehrig; I Leivo; W S Argraves; E Ruoslahti; E Engvall
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

4.  Abnormal localization of laminin subunits in muscular dystrophies.

Authors:  Y K Hayashi; E Engvall; E Arikawa-Hirasawa; K Goto; R Koga; I Nonaka; H Sugita; K Arahata
Journal:  J Neurol Sci       Date:  1993-10       Impact factor: 3.181

5.  Fibronectin: purification, immunochemical properties, and biological activities.

Authors:  E Ruoslahti; E G Hayman; M Pierschbacher; E Engvall
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

6.  Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations.

Authors:  Y Fukuyama; M Osawa; H Suzuki
Journal:  Brain Dev       Date:  1981       Impact factor: 1.961

7.  Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33.

Authors:  T Toda; M Segawa; Y Nomura; I Nonaka; K Masuda; T Ishihara; M Sakai; I Tomita; Y Origuchi; M ] Suzuki M [corrected to Sakai
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

8.  Expression of merosin in the thymus and its interaction with thymocytes.

Authors:  A C Chang; S Wadsworth; J E Coligan
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

9.  A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

Authors:  J M Ervasti; K P Campbell
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

10.  Galloylglucoses of low molecular weight as mordant in electron microscopy. I. Procedure, and evidence for mordanting effect.

Authors:  N Simionescu; M Simionescu
Journal:  J Cell Biol       Date:  1976-09       Impact factor: 10.539

View more
  53 in total

Review 1.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Comparative proteomic profiling of dystroglycan-associated proteins in wild type, mdx, and Galgt2 transgenic mouse skeletal muscle.

Authors:  Jung Hae Yoon; Eric Johnson; Rui Xu; Laura T Martin; Paul T Martin; Federica Montanaro
Journal:  J Proteome Res       Date:  2012-07-30       Impact factor: 4.466

3.  Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy.

Authors:  P H Vachon; H Xu; L Liu; F Loechel; Y Hayashi; K Arahata; J C Reed; U M Wewer; E Engvall
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

4.  Differential expression of mRNAs encoding laminin chain variants during in vitro development of mouse blastocysts.

Authors:  M Azimi; T Niimi; N Yoshida; Y Kitagawa
Journal:  Cytotechnology       Date:  1999-09       Impact factor: 2.058

Review 5.  The muscular dystrophies: from genes to therapies.

Authors:  Richard M Lovering; Neil C Porter; Robert J Bloch
Journal:  Phys Ther       Date:  2005-12

6.  Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models.

Authors:  W Kuang; H Xu; P H Vachon; L Liu; F Loechel; U M Wewer; E Engvall
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

7.  Amelioration of laminin-alpha2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin.

Authors:  Chunping Qiao; Jianbin Li; Tong Zhu; Romesh Draviam; Simon Watkins; Xiaojing Ye; Chunlian Chen; Juan Li; Xiao Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

8.  Expression of laminin subunits in human fetal skeletal muscle.

Authors:  C A Sewry; M Chevallay; F M Tomé
Journal:  Histochem J       Date:  1995-07

9.  Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.

Authors:  Karen Fernandez; Yelda Serinagaoglu; Sue Hammond; Laura T Martin; Paul T Martin
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

10.  Muscular dystrophy associated with alpha-dystroglycan deficiency in Sphynx and Devon Rex cats.

Authors:  Paul T Martin; G Diane Shelton; Peter J Dickinson; Beverly K Sturges; Rui Xu; Richard A LeCouteur; Ling T Guo; Robert A Grahn; Harriet P Lo; Kathryn N North; Richard Malik; Eva Engvall; Leslie A Lyons
Journal:  Neuromuscul Disord       Date:  2008-11-05       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.